Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487981 · ClinicalTrials.gov registry record · Phase 4
Spinal Cord Stimulation for Painful Diabetic Neuropathy
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT00487981 is a Phase 4 study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 1 participants.
The verdict
NCT00487981, a Phase 4 study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate Spinal Cord Stimulation (SCS) therapy in individuals who suffer from painful diabetic peripheral neuropathy. Patients invited to participate in this study will be eligible for SCS therapy, and will have already selected therapy with the Advanced Bionics Precision system independent of possible inclusion in this study. The device, accessories, and procedures associated with device placement and the indications for use are all consistent with the current and approved product labeling.
Interventions
- DEVICE Precision Spinal Cord Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487981
The ClinicalTrials.gov registry entry for NCT00487981 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Precision Spinal Cord Stimulation is the first listed.
NCT00487981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487981 about?
NCT00487981 is a clinical study titled "Spinal Cord Stimulation for Painful Diabetic Neuropathy". The purpose of this study is to evaluate Spinal Cord Stimulation (SCS) therapy in individuals who suffer from painful diabetic peripheral neuropathy. Patients invited to participate in this study will be eligible for SCS therapy, and will have already selected therapy with the Advanced Bionics Preci...
What is the current status of trial NCT00487981?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2007-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00487981?
The interventions under investigation include: Precision Spinal Cord Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00487981?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.